Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients

SIMPLE SUMMARY: Oncolytic viruses (OVs) have been extensively studied as an immunotherapeutic agent against a variety of cancers with some successes. Immunotherapeutic strategies, such as OVs, aim to transform an immunologically ‘cold’ tumour microenvironment into a more favourable inflammatory ‘hot...

Descripción completa

Detalles Bibliográficos
Autores principales: West, Emma J., Scott, Karen J., Tidswell, Emma, Bendjama, Kaidre, Stojkowitz, Nicolas, Lusky, Monika, Kurzawa, Marta, Prasad, Raj, Toogood, Giles, Ralph, Christy, Anthoney, D. Alan, Melcher, Alan A., Collinson, Fiona J., Samson, Adel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103071/
https://www.ncbi.nlm.nih.gov/pubmed/35565310
http://dx.doi.org/10.3390/cancers14092181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103071/
https://www.ncbi.nlm.nih.gov/pubmed/35565310
http://dx.doi.org/10.3390/cancers14092181

Ejemplares similares